FDA Approves Unknown Drug — IPCA LABS LTD
FDA has approved the generic version of the referenced drug manufactured by IPCA LABS LTD, representing a new entry in the market. The anticipated approval creates a competitive la…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
FDA has approved the generic version of the referenced drug manufactured by IPCA LABS LTD, representing a new entry in the market. The anticipated approval creates a competitive la…
# FDA Approves Generic Sitagliptin and Metformin Hydrochloride Combination Apotex Corp. received FDA approval for its generic sitagliptin and metformin hydrochloride combination t…
# FDA Approves BPI Labs' Generic Fluorescein Sodium for Intravenous Use The FDA has approved BPI Labs LLC's abbreviated new drug application for generic fluorescein sodium injecti…
UNICHEM announced FDA approval of ANDA 219593 effective April 30, 2026, a milestone expected to bolster its market presence and diversify its revenue streams within the generic pha…
LUPIN has received FDA approval for ANDA 207694, a move that is likely to strengthen the company’s competitive positioning and broaden its market share in the relevant therapeutic …
# FDA Approves Sunshine Lake Pharma Biologic Application The U.S. Food and Drug Administration has approved Biologics License Application (BLA) 761412 for Sunshine Lake Pharma Co …
# FDA Approves HUMANWELL's Generic Drug Application HUMANWELL has received FDA approval for its abbreviated new drug application (ANDA 218740), potentially expanding its portfolio…
# FDA Approves Sun Pharma Canada Generic Drug Sun Pharma Canada has received FDA approval for a generic drug application (ANDA213919), expanding the company's portfolio in the com…
Biocon Pharma’s acquisition of an FDA approval for a generic drug substance on April 28, 2026, is anticipated to expand its United States market footprint and drive future top-line…
Micro Labs is poised to capitalize on the upcoming approval, with the generic launch expected to introduce competitive pricing pressures and capture market share from established b…
# FDA Approves Generic Fingolimod; Alembic Pharmaceuticals Enters Multiple Sclerosis Market The FDA has approved Alembic Pharmaceuticals Inc.'s generic fingolimod hydrochloride or…
# FDA Approves Generic Glycerol Phenylbutyrate; Zydus Pharmaceuticals Entry Expected to Intensify Competition The FDA has granted approval to Zydus Pharmaceuticals USA Inc. for a …
SciGen Pharmaceuticals is positioned for potential revenue growth and market entry following the FDA approval of its ANDA, a regulatory clearance expected to drive investor optimis…
# FDA Approves Anthea Pharma's Generic Bupivacaine Hydrochloride for Epidural Use Anthea Pharma Private Limited received FDA approval for its generic bupivacaine hydrochloride epi…
SHUANGCHENG has received FDA approval for ANDA 219973, marking a strategic entry into the U.S. market and solidifying the company's ability to generate immediate revenue through ma…
The FDA approved Unknown Drug from OMSAV PHARMA under application ANDA218093 on 2026-04-22.
Cipla USA Inc. received FDA approval for the generic albuterol sulfate inhalation product, ANDA219409, marking a critical milestone as the branded competitor prepares for patent ex…
# FDA Approves Apotex Generic Drug Application Apotex received FDA approval for ANDA210456 on April 21, 2026, marking another addition to the Canadian manufacturer's generic portf…
# FDA Approves Sandoz Generic Drug Application Sandoz received FDA approval for an abbreviated new drug application (ANDA216068) on April 20, 2026, potentially expanding the compa…
# FDA Approves Merck's IDVYNSO (Doravirine/Islatravir) for HIV Treatment Merck Sharp & Dohme LLC has received FDA approval for IDVYNSO, an oral combination therapy featuring dorav…